Chelsea A E Hicks
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chelsea A E Hicks has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Séverine Tasker
Bristol Veterinary School, University of Bristol, Bristol BS40 5DU, UK
4 shared publications - Chris Helps
University of Bristol
2 shared publications - Emily N. Barker
Langford Vets, University of Bristol, Langford BS40 5DU, UK
2 shared publications - A. Douglas Wilson
University of Bristol, Clinical Research and Imaging Centre, Bristol, United Kingdom
1 shared publication A.M. Haruna
State Veterinary Hospital Jos, Ministry of Agriculture and Natural Resources, Plateau State, Nigeria
1 shared publicationBarbara Riond
Clinical Laboratory, Vetsuisse Facility, University of Zurich, Zurich, Switzerland
1 shared publication
Latest Publications
- Open Access
- 1 March 2017
- Published by Elsevier in Ticks and Tick-borne Diseases
- Vol. 8 (3) , 341-346
Canine tick-borne pathogens in Cyprus and a unique canine case of multiple co-infections
- 1 March 2017
- Published by Elsevier in Ticks and Tick-borne Diseases
- Vol. 8 (3) , 341-346
Open AccessCanine tick-borne pathogens in Cyprus and a unique canine case of multiple co-infections
- Open Access
- 9 May 2016
- Published by Springer Nature in Veterinary Research
- Vol. 47 (1) , 1-14
Both tumour cells and infiltrating T-cells in equine sarcoids express FOXP3 associated with an immune-supressed cytokine microenvironment
Bovine papillomavirus (BPV) infections of equine species have a central role in the aetiology of equine sarcoids; a common benign skin tumour of horses, zebras and donkeys. Within the lesions, all of the early papillomavirus genes are expressed and promote the excessive replication of fibroblasts which characterise these tumours. Equine sarcoids differ from BPV induced fibro-papillomas of cattle (the natural host of BPV), in that they do not produce high amounts of virus particles, do not usually regress spontaneously and do not sero-convert to BPV; features which suggest that affected horses lack an effective anti-viral immune response to BPV. Equine sarcoids contain large numbers of CD4+ CD8+ dual positive T-cells which uniformly express FOXP3, the key transcription factor of regulatory T-cells, and FOXP3 is also expressed within the BPV infected fibroblasts. Compared to healthy skin, sarcoids showed increased mRNA transcription for FOXP3 and the regulatory cytokine TGFβ. Transcription of IL17, which has been shown to have a regulatory function in human papillomavirus-associated tumours, was also elevated in equine sarcoids compared to spleen. In contrast, the levels of mRNA transcripts for effector T cell cytokines IL2, IL4 and interferon-gamma (IFNγ) were not elevated in sarcoids compared to healthy skin or spleen. Similarly neither interferon-alpha (IFNα), interferon-beta (IFNβ) nor IL12 family members were elevated in sarcoids compared to normal skin. We suggest that the regulatory cytokine micro-environment within sarcoids enables the persistence of the lesions by preventing an effective anti-viral immune response.
- 9 May 2016
- Published by Springer Nature in Veterinary Research
- Vol. 47 (1) , 1-14
Open AccessBoth tumour cells and infiltrating T-cells in equine sarcoids express FOXP3 associated with an immune-supressed cytokine microenvironment
Bovine papillomavirus (BPV) infections of equine species have a central role in the aetiology of equine sarcoids; a common benign skin tumour of horses, zebras and donkeys. Within the lesions, all of the early papillomavirus genes are expressed and promote the excessive replication of fibroblasts which characterise these tumours. Equine sarcoids differ from BPV induced fibro-papillomas of cattle (the natural host of BPV), in that they do not produce high amounts of virus particles, do not usually regress spontaneously and do not sero-convert to BPV; features which suggest that affected horses lack an effective anti-viral immune response to BPV. Equine sarcoids contain large numbers of CD4+ CD8+ dual positive T-cells which uniformly express FOXP3, the key transcription factor of regulatory T-cells, and FOXP3 is also expressed within the BPV infected fibroblasts. Compared to healthy skin, sarcoids showed increased mRNA transcription for FOXP3 and the regulatory cytokine TGFβ. Transcription of IL17, which has been shown to have a regulatory function in human papillomavirus-associated tumours, was also elevated in equine sarcoids compared to spleen. In contrast, the levels of mRNA transcripts for effector T cell cytokines IL2, IL4 and interferon-gamma (IFNγ) were not elevated in sarcoids compared to healthy skin or spleen. Similarly neither interferon-alpha (IFNα), interferon-beta (IFNβ) nor IL12 family members were elevated in sarcoids compared to normal skin. We suggest that the regulatory cytokine micro-environment within sarcoids enables the persistence of the lesions by preventing an effective anti-viral immune response.
- Open Access
- 1 May 2016
- Published by Elsevier in Veterinary Parasitology
- Vol. 221, 111-117
Analysis of risk factors and prevalence of haemoplasma infection in dogs
- 1 May 2016
- Published by Elsevier in Veterinary Parasitology
- Vol. 221, 111-117
Open AccessAnalysis of risk factors and prevalence of haemoplasma infection in dogs
- Open Access
- 19 November 2014
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 22 (1) , 108-118
Protective Immunity against Infection with Mycoplasma haemofelis
Hemoplasmas are potentially zoonotic mycoplasmal pathogens, which are not consistently cleared by antibiotic therapy.Mycoplasma haemofelisis the most pathogenic feline hemoplasma species. The aim of this study was to determine how cats previously infected withM. haemofelisthat had recovered reacted when rechallenged withM. haemofelisand to characterize the immune response followingde novoM. haemofelisinfection and rechallenge. Five specific-pathogen-free (SPF)-derived naive cats (group A) and five cats that had recovered fromM. haemofelisinfection (group B) were inoculated subcutaneously withM. haemofelis. BloodM. haemofelisloads were measured by quantitative PCR (qPCR), antibody response to heat shock protein 70 (DnaK) by enzyme-linked immunosorbent assay (ELISA), blood lymphocyte cell subtypes by flow cytometry, and cytokine mRNA levels by quantitative reverse transcriptase PCR. Group A cats all became infected with high bacterial loads and seroconverted, while group B cats were protected from reinfection, thus providing the unique opportunity to study the immunological parameters associated with this protective immune response againstM. haemofelis. First, a strong humoral response to DnaK was only observed in group A, demonstrating that an antibody response to DnaK is not important for protective immunity. Second, proinflammatory cytokine interleukin-6 (IL-6) mRNA levels appeared to increase rapidly postinoculation in group B, indicating a possible role in protective immunity. Third, an increase in IL-12p35 and -p40 mRNA and decrease in the Th2/Th1 ratio observed in group A suggest that a Th1-type response is important in primary infection. This is the first study to demonstrate protective immunity againstM. haemofelisreinfection, and it provides important information for potential future hemoplasma vaccine design.
- 19 November 2014
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 22 (1) , 108-118
Open AccessProtective Immunity against Infection with Mycoplasma haemofelis
Hemoplasmas are potentially zoonotic mycoplasmal pathogens, which are not consistently cleared by antibiotic therapy.Mycoplasma haemofelisis the most pathogenic feline hemoplasma species. The aim of this study was to determine how cats previously infected withM. haemofelisthat had recovered reacted when rechallenged withM. haemofelisand to characterize the immune response followingde novoM. haemofelisinfection and rechallenge. Five specific-pathogen-free (SPF)-derived naive cats (group A) and five cats that had recovered fromM. haemofelisinfection (group B) were inoculated subcutaneously withM. haemofelis. BloodM. haemofelisloads were measured by quantitative PCR (qPCR), antibody response to heat shock protein 70 (DnaK) by enzyme-linked immunosorbent assay (ELISA), blood lymphocyte cell subtypes by flow cytometry, and cytokine mRNA levels by quantitative reverse transcriptase PCR. Group A cats all became infected with high bacterial loads and seroconverted, while group B cats were protected from reinfection, thus providing the unique opportunity to study the immunological parameters associated with this protective immune response againstM. haemofelis. First, a strong humoral response to DnaK was only observed in group A, demonstrating that an antibody response to DnaK is not important for protective immunity. Second, proinflammatory cytokine interleukin-6 (IL-6) mRNA levels appeared to increase rapidly postinoculation in group B, indicating a possible role in protective immunity. Third, an increase in IL-12p35 and -p40 mRNA and decrease in the Th2/Th1 ratio observed in group A suggest that a Th1-type response is important in primary infection. This is the first study to demonstrate protective immunity againstM. haemofelisreinfection, and it provides important information for potential future hemoplasma vaccine design.
- Open Access
- 1 April 2014
- Published by Elsevier in Infection, Genetics and Evolution
- Vol. 23 (100) , 99-105
Non-ribosomal phylogenetic exploration of Mollicute species: New insights into haemoplasma taxonomy
- 1 April 2014
- Published by Elsevier in Infection, Genetics and Evolution
- Vol. 23 (100) , 99-105
Open AccessNon-ribosomal phylogenetic exploration of Mollicute species: New insights into haemoplasma taxonomy